skip to content

CATALYST News

Earnings Insight

Earnings Calendar

Date Time Symbol company_name Period Metric Estimate Actual Surprise YrAgo Growth sector_industry
05/29/2026 BMO BKE Buckle Q1 2026 EPS 0.74 0.70
05/29/2026 BMO BKE Buckle Q1 2026 REV 289.22 M 272.12 M
05/29/2026 BMO GCO Genesco Q1 2027 EPS -2.56 -2.05
05/29/2026 BMO GCO Genesco Q1 2027 REV 475.00 M 473.97 M
05/28/2026 BMO ALAR Alarum Technologies Q1 2026 EPS 0.16
05/28/2026 BMO ALAR Alarum Technologies Q1 2026 REV 7.13 M
05/28/2026 BMO ARBE Arbe Robotics Q1 2026 EPS -0.09
05/28/2026 BMO ARBE Arbe Robotics Q1 2026 REV
05/28/2026 BMO ATHM Autohome Q1 2026 EPS 0.31 0.49
05/28/2026 BMO ATHM Autohome Q1 2026 REV 188.91 M 200.34 M

Pre-Market Insights

Pre-Market Movers

Date Time Symbol Company Name Last Updated PrevClose Price Change Percent stockprice52wklow stockprice52wkhigh 52Wk Range company_sector company_industry Sector / Industry dailyvolume marketcap news_link Catalyst News
05/29/2026 07:04 PM SLXN Silexion Therapeutics Ltd. 29-May 09:19 4.91 4.29 3.87 921.43 2.31 223.60 $2.31 ~ $223.60 Healthcare Biotechnology 295.65 2.05
05/29/2026 07:05 PM HUBC HUB Cyber Security Ltd. 29-May 09:20 0.26 0.38 0.27 245.45 0.10 3,322.50 $0.10 ~ $3,322.50 Technology Software - Infrastructure 1,297.20 10.00
05/29/2026 07:05 PM PRFX PRF Technologies Ltd. 29-May 09:20 3.00 4.54 3.15 226.62 1.28 17.95 $1.28 ~ $17.95 Healthcare Drug Manufacturers - Specialty & Generic 55.53 240.00
05/29/2026 07:04 PM HKIT Hitek Global Inc. 29-May 09:20 1.75 1.66 1.12 207.41 1.50 627.00 $1.50 ~ $627.00 Technology Software - Application 728.10 340.00
05/29/2026 07:05 PM STG Sunlands Technology Group 29-May 09:20 6.10 5.39 2.72 101.87 2.62 15.00 $2.62 ~ $15.00 Consumer Defensive Education & Training Services 24.58 82.18
05/29/2026 07:04 PM REPL Replimune Group, Inc. 29-May 09:20 8.69 8.64 3.96 84.62 1.50 13.24 $1.50 ~ $13.24 Healthcare Biotechnology 50.86 717.56 Replimune to resubmit twice-rejected drug for approval after FDA shakeup
CNBC | 2026-05-29 08:51:06
Replimune reaches agreement with US FDA to resubmit melanoma drug application
Reuters | 2026-05-29 08:07:19
Replimune Gets Third Try at FDA Approval After Makary Departure
WSJ | 2026-05-29 07:30:00
05/29/2026 07:05 PM DEVS DevvStream Corp. Common Stock 29-May 09:20 0.28 0.23 0.10 76.92 0.11 10.10 $0.11 ~ $10.10 Industrials Pollution & Treatment Controls 563.49 1.21 DevvStream, XCF Global, and Southern Energy Renewables Confirm Three-Party Business Combination Remains on Track
GuruFocus | 2026-05-29 10:00:00
05/29/2026 07:05 PM IOTR iOThree Limited Ordinary Shares 29-May 09:20 3.91 4.73 1.93 68.93 1.51 7.47 $1.51 ~ $7.47 Communication Services Telecom Services 21.63 10.03
05/29/2026 07:04 PM CMND Clearmind Medicine Inc. 29-May 09:20 3.58 3.47 1.02 41.63 2.10 524.00 $2.10 ~ $524.00 Healthcare Biotechnology 44.50 3.65
05/29/2026 07:04 PM DELL Dell Technologies Inc. 29-May 09:20 421.30 421.50 103.49 32.54 106.38 429.15 $106.38 ~ $429.15 Technology Computer Hardware 38.18 284.38 Jim Cramer says Dell's blowout quarter sets up a crucial week for AI stocks
CNBC | 2026-05-29 18:18:08
Dell Technologies Crushes Earnings: AI Buildout Remains Robust
Zacks Investment Research | 2026-05-29 17:36:05
Stock Market Gains As Trump Mulls Iran Ceasefire; Dell Soars, Jobs Report Due
Investors Business Daily | 2026-05-29 17:31:56
Dell Stock Rally Shakes Up World's Richest List: Michael Dell Passes Mark Zuckerberg For Sixth Place
Benzinga | 2026-05-29 16:48:03
Dell Stock Soars 33% as Earnings Blow Past Wall Street Expectations
Investopedia | 2026-05-29 16:45:36

Bio-Pharm Insight

FDA Calendar

Date Symbol Company time event_type Drug Drug Details Status Catalyst target_date_from target_date_to Catalyst Summary Source
05/19/2026 CGEM Cullinan Therapeutics 07:00 AM FDA Decision CLN-049 CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia Phase 1 Orphan Drug Designation 05/19/2026 05/19/2026 Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
09/05/2025 CERO CERo Therapeutics Holdings 08:00 AM FDA Decision CER-1236 For the treatment of Acute Myeloid Leukemia (AML) Phase 2 Fast Track Designation 09/05/2025 09/05/2025
09/04/2025 AMRX Amneal Pharmaceuticals 04:01 PM FDA Decision Risperdal Consta An extended-release injectable suspension 12.5 mg/vial, 25 mg/vial, 37.5 mg/vial and 50 mg/vial, Approved FDA Approval 09/04/2025 09/04/2025
09/04/2025 LLY Eli Lilly and Company 07:45 AM FDA Decision Olomorasib + KEYTRUDA (pembrolizumab) For the first-line treatment of patients with unresectable advanced or metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation and PD-L1 expression = 50% SUNRAY-01 Phase 3 Breakthrough Therapy designation 09/04/2025 09/04/2025
07/02/2025 TIL Instil Bio 06:00 AM FDA Decision AXN-2510 A PD-L1xVEGF Bispecific Antibody, for the treatment of Relapsed/Refractory Solid Tumors Phase 1 Investigational New Drug (IND) 11/30/-0001 11/30/-0001 Instil Bio, Inc. (TIL) announced that the U.S. Food and Drug Administration has cleared an Investigational New Drug (IND) application for AXN-2510. Instil Bio plans to initiate a phase 1 trial of 2510 as monotherapy for patients with relapsed/refractory solid tumors before the end of 2025. The trial is designed to evaluate the safety of 2510 in patients with solid tumors. It also aims to assess the efficacy of the treatment. Additionally, the study will examine the pharmacokinetics and pharmacodynamics of the drug.
07/02/2025 REGN Regeneron Pharmaceuticals 11:00 AM FDA Decision Lynozyfic™ (linvoseltamab-gcpt) To treat adult patients with relapsed or refractory (R/R) multiple myeloma (MM) who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti‑CD38 monoclonal antibody. Approved FDA Accelerated Approval 11/30/-0001 11/30/-0001 Regeneron Pharmaceuticals, Inc. (REGN) announced that the U.S. Food and Drug Administration has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. These therapies include a proteasome inhibitor, an immunomodulatory agent, and an anti‑CD38 monoclonal antibody. Lynozyfic was granted accelerated approval based on response rate and durability of response in the LINKER-MM1 trial.
06/30/2025 TAK Takeda 08:00 AM FDA Decision GAMMAGARD LIQUID ERC [immune globulin infusion (human)] Intravenous or Subcutaneous Use in People Aged Two and Older with Primary Immunodeficiency Approved FDA Approval 11/30/-0001 11/30/-0001 Takeda (TAK) announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC immune globulin infusion (human) with less than or equal to 2 µg/mL IgA in a 10% solution. It is the only ready-to-use liquid immunoglobulin therapy with low immunoglobulin A content. The therapy is approved as a replacement treatment for people two years of age and older with primary immunodeficiency.

After Hour Movers

Date Time Symbol Company Name Last Updated Close Price Change Percent Day Range 52Wk Range Sector / Industry dailyvolume marketcap news_link Catalyst News
05/29/2026 07:05 PM NAMM Namib Minerals Ordinary Shares 29-May 19:05 1.52 2.32 0.80 52.63 $1.41 ~ $1.62 $0.91 ~ $55.00 540.90 82.81
05/29/2026 04:56 PM PAVM PAVmed Inc. 29-May 16:56 6.20 8.00 1.80 29.03 $6.11 ~ $6.34 $6.00 ~ $28.44 10.68 3.33
05/29/2026 07:05 PM LSTA Lisata Therapeutics, Inc. 29-May 19:05 3.25 4.16 0.91 28.00 $3.18 ~ $3.36 $1.81 ~ $5.07 173.29 29.60
05/29/2026 07:05 PM HCWC Healthy Choice Wellness Corp. 29-May 19:05 0.33 0.42 0.09 27.27 $0.29 ~ $0.35 $0.22 ~ $0.98 662.35 5.53
05/29/2026 05:14 PM KINS Kingstone Companies, Inc. 29-May 17:14 14.87 18.64 3.77 25.35 $14.84 ~ $15.47 $13.08 ~ $19.42 99.13 215.39
05/29/2026 07:05 PM HUBC HUB Cyber Security Ltd. 29-May 19:05 0.26 0.32 0.06 23.08 $0.25 ~ $0.63 $0.10 ~ $3,322.50 1,297.20 10.00
05/29/2026 07:05 PM GFAI Guardforce AI Co., Limited 29-May 19:05 0.53 0.65 0.12 22.64 $0.49 ~ $0.53 $0.38 ~ $1.50 324.05 11.62
05/29/2026 05:33 PM AVXL Anavex Life Sciences Corp. 29-May 17:33 3.03 3.70 0.67 22.11 $2.82 ~ $3.04 $2.61 ~ $13.99 1.12 280.80
05/29/2026 07:05 PM WNW Meiwu Technology Company Limited 29-May 19:05 4.04 4.63 0.59 14.60 $3.67 ~ $4.87 $2.25 ~ $1,352.00 10.55 130.00
05/29/2026 07:45 AM TCGL TechCreate Group Ltd. 29-May 07:45 172.84 196.71 23.87 13.81 $161.13 ~ $355.00 $3.95 ~ $355.00 1.12 3.53

After Hour Insights

© Catalyst picR 2025-26